These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 29324935

  • 1. Right putamen and age are the most discriminant features to diagnose Parkinson's disease by using 123I-FP-CIT brain SPET data by using an artificial neural network classifier, a classification tree (ClT).
    Cascianelli S, Tranfaglia C, Fravolini ML, Bianconi F, Minestrini M, Nuvoli S, Tambasco N, Dottorini ME, Palumbo B.
    Hell J Nucl Med; 2017; 20 Suppl():165. PubMed ID: 29324935
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. An FP-CIT PET comparison of the difference in dopaminergic neuronal loss in subtypes of early Parkinson's disease.
    Song IU, Chung YA, Oh JK, Chung SW.
    Acta Radiol; 2014 Apr; 55(3):366-71. PubMed ID: 23943629
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. 18F-FP-CIT PET imaging and SPM analysis of dopamine transporters in Parkinson's disease in various Hoehn & Yahr stages.
    Wang J, Zuo CT, Jiang YP, Guan YH, Chen ZP, Xiang JD, Yang LQ, Ding ZT, Wu JJ, Su HL.
    J Neurol; 2007 Feb; 254(2):185-90. PubMed ID: 17334953
    [Abstract] [Full Text] [Related]

  • 7. Dopamine transporter imaging (123)I-FP-CIT (DaTSCAN) SPET in differential diagnosis of dopa-responsive dystonia and young-onset Parkinson's disease.
    Brajkovic LD, Svetel MV, Kostic VS, Sobic-Saranovic DP, Pavlovic SV, Artiko VM, Obradovic VB.
    Hell J Nucl Med; 2012 Feb; 15(2):134-8. PubMed ID: 22833860
    [Abstract] [Full Text] [Related]

  • 8. [123I]-FP/CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson's disease.
    Lorberboym M, Treves TA, Melamed E, Lampl Y, Hellmann M, Djaldetti R.
    Mov Disord; 2006 Apr; 21(4):510-4. PubMed ID: 16250023
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. 123I-FP-CIT brain SPECT (DaTSCAN) imaging in the diagnosis of patients with movement disorders--first results.
    Jauković L, Ilić TV, Dopudja M, Ajdinović B.
    Vojnosanit Pregl; 2012 Feb; 69(2):157-62. PubMed ID: 22500370
    [Abstract] [Full Text] [Related]

  • 12. [Quantitative evaluation of 123I-FP-CIT SPECT: validation of a semiautomated method].
    Lorenzo Bosquet C, Cuberas Borrós G, Miquel Rodríguez F, Caresia P, Aguadé Bruix S, Castell Conesa J.
    Rev Esp Med Nucl; 2005 Feb; 24(4):244-9. PubMed ID: 16122408
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Smoking in Patients with Parkinson's Disease: preliminary striatal DaT-SPECT findings.
    Gigante AF, Defazio G, Niccoli Asabella A, Superbo M, Ferrari C, Liuzzi D, Iliceto G, Livrea P, Rubini G.
    Acta Neurol Scand; 2016 Oct; 134(4):265-70. PubMed ID: 26659996
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.